Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
232studies shown
Showing 101-125 of 232
RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
RecruitingNCT06341426

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

This study is looking at see if one or two doses of psilocybin is more effective in relieving depressive symptoms in patients with treatment-resistant depression (TRD) for people with depression or Treatment-Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University Health Network, Toronto
Condition
Depression
RecruitingNCT05097586

RCT of At-Home tDCS for Depression in Pregnancy

This study is looking at care and outcomes for people with Major Depression, Pregnancy, or Postpartum Depression. Some participants may receive control instead of the study treatment, and direct benefit is not guaranteed.

DepressionDeviceOver 18 Years
Countries
Canada
Sponsor
Women's College Hospital
Condition
Depression
RecruitingNCT05527509

Risk and Resiliency Factors in the RCMP: A Prospective Investigation

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionBehavioralFrom 19 Years to 57 Years
Countries
Canada
Sponsor
University of Regina
Condition
Depression
RecruitingNCT06029439

Study to Assess the Safety and Effectiveness of NMRA-335140-501

This study is looking at care and outcomes for people with depression. Taking part may give some people access to NMRA-335140, but direct benefit is not guaranteed.

DepressionOtherFrom 18 Years to 65 Years
Countries
Brazil, Bulgaria, Canada, Chile, Czech Republic, Finland, France, Germany, Poland, Sweden, United States
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
RecruitingNCT05295888

Temporal Interference and Depression

This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.

DepressionDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Unity Health Toronto
Condition
Depression
RecruitingNCT06163625

The Impact of Working Memory and Reward Markers on DLPFC Activity in Treatment-resistant Depression

This study is comparing Repetitive Transcranial Magnetic Stimulation with Control Group for people with depression or Treatment Resistant Depression. Participants receive Repetitive Transcranial Magnetic Stimulation or Control Group and complete study visits and assessments.

DepressionDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Unity Health Toronto
Condition
Depression
RecruitingNCT07033780

Theta-Burst Stimulation to Treat Depression

This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDeviceFrom 18 Years to 50 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
RecruitingNCT04257227

Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness

This study is looking at whether a digital support tool can help people with Depressive Symptoms, Depression, Anxiety, Psychological Distress, or Terminal Illness. Participants receive repetitive Transcranial Magnetic Stimulation (rTMS) or sham treatment and complete study visits and assessments.

DepressionDeviceOver 18 Years
Countries
Canada
Sponsor
Ottawa Hospital Research Institute
Condition
Depression
RecruitingNCT06493071

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI

This study is looking at explore a novel and non-invasive treatment strategy for depression in individuals with spinal cord injury for people with Spinal Cord Injury or Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionDeviceOver 18 Years
Countries
Canada
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition
Depression
RecruitingNCT05002309

Treatment Interrupts Depression Early

This study is looking at whether a digital support tool can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDrugFrom 12 Years to 25 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression
RecruitingNCT06891300

Understanding and Treating Suicidal Ideation With Ketamine

This study is looking at whether a digital support tool can help people with Suicidal Ideation or depression. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
The Royal's Institute of Mental Health Research
Condition
Depression
RecruitingNCT06780917

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment

This study is looking at validate the Creyos online cognitive assessment platform in individuals with mild cognitive impairment, or remitted major depressive disorder for people with Mild Cognitive Impairment, depression, Remitted, or Healthy Controls Group - Age and Sex-matched. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherOver 60 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
RecruitingNCT06546917

bWell-D Pilot Randomized Controlled Trial

This study is looking at whether bWell Cognitive Remediation can help people with major depression or Cognitive Dysfunction. Participants take part in bWell Cognitive Remediation and complete follow-up assessments.

DepressionOtherFrom 19 Years to 55 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Depression
RecruitingNCT06480500

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

This study is looking at whether internet-based cognitive behavioural therapy can help people with depression, Suicide, or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 21 Years to 65 Years
Countries
Canada
Sponsor
University Health Network, Toronto
Condition
Depression
RecruitingNCT06121284

iTBS+D-Cycloserine for Youth Suicide

This study is comparing D-Cycloserine with placebo for people with Suicidal Ideation, Suicide, Attempted, or Depression, Anxiety. Participants receive D-Cycloserine or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 24 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Depression
RecruitingNCT06719427

qEEG Brain Signature of Depression & Neuromodulation-induced Recovery

This study is looking at explore how repetitive transcranial magnetic stimulation (rTMS), a treatment for depression, affects brain function for people with Major Depressive Diorder. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDeviceFrom 18 Years to 80 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression
Canada | Clinical Trials | HopeStage Research